日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CCDC6 Immunostaining in Conjunction with the Rad51 HRD Assay May Expand PARPi Treatment Eligibility in Patients with HGSOC

CCDC6免疫染色联合Rad51 HRD检测可能扩大PARP抑制剂治疗在高级别浆液性卵巢癌患者中的适用范围。

Daniela Criscuolo,Francesco Merolla,Benedetta Pellegrino,Luca Russolillo,Ilaria De Benedictis,Daniela Califano,Rosaria Catalano,Carmela Baviello,Silvia Varricchio,Sabrina C Cecere,Camilla Nero,Eleonora Palluzzi,Dionyssios Katsaros,Ettore D Capoluongo,Giovanni L Scaglione,Sergio Marchini,Daniela Russo,Anna Spina,Laura Arenare,Francesco Morra,Maria Marotta,Marialuisa A Vecchione,Alexandra Ingallinella,Francesco Perrone,Sandro Pignata,Angela Celetti

Suppression of ADP-ribosylation reversal triggers cell vulnerability to alkylating agents

抑制 ADP 核糖基化逆转引发细胞对烷化剂的易感性

Rocco Caggiano, Evgeniia Prokhorova, Lena Duma, Kira Schützenhofer, Raffaella Lauro, Giuliana Catara, Rosa Marina Melillo, Angela Celetti, Rebecca Smith, S John Weroha, Scott H Kaufmann, Ivan Ahel, Luca Palazzo

The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinoma

CCDC6 - PP4 轴的破坏会在高级别浆液性卵巢癌中诱导 BRCAness 样表型和对 PARP 抑制剂的敏感性

Francesco Morra #, Francesco Merolla #, Giovanna Damia, Francesca Ricci, Silvia Varricchio, Gennaro Ilardi, Laura Arenare, Daniela Califano, Virginia Napolitano, Robert Fruscio, Rosa Marina Melillo, Luca Palazzo, Angela Celetti

The tumour suppressor CCDC6 is involved in ROS tolerance and neoplastic transformation by evading ferroptosis

肿瘤抑制因子 CCDC6 通过逃避铁死亡参与 ROS 耐受和肿瘤转化

Francesco Morra, Francesco Merolla, Federica Zito Marino, Rosaria Catalano, Renato Franco, Paolo Chieffi, Angela Celetti

Neuropilin-1 Expression Associates with Poor Prognosis in HNSCC and Elicits EGFR Activation upon CDDP-Induced Cytotoxic Stress

神经纤毛蛋白-1 表达与 HNSCC 预后不良相关,并在 CDDP 诱导的细胞毒性应激后引发 EGFR 激活

Virginia Napolitano, Daniela Russo, Francesco Morra, Francesco Merolla, Silvia Varricchio, Gennaro Ilardi, Rosa Maria Di Crescenzo, Francesco Martino, Massimo Mascolo, Angela Celetti, Luca Tamagnone, Stefania Staibano

CAF-1 Subunits Levels Suggest Combined Treatments with PARP-Inhibitors and Ionizing Radiation in Advanced HNSCC

CAF-1 亚基水平提示晚期 HNSCC 应联合使用 PARP 抑制剂和电离辐射治疗

Francesco Morra, Francesco Merolla, Ida Picardi, Daniela Russo, Gennaro Ilardi, Silvia Varricchio, Federica Liotti, Roberto Pacelli, Luca Palazzo, Massimo Mascolo, Angela Celetti, Stefania Staibano

The combined effect of USP7 inhibitors and PARP inhibitors in hormone-sensitive and castration-resistant prostate cancer cells

USP7 抑制剂与 PARP 抑制剂对激素敏感型和去势抵抗型前列腺癌细胞的联合作用

Francesco Morra, Francesco Merolla, Virginia Napolitano, Gennaro Ilardi, Caterina Miro, Simona Paladino, Stefania Staibano, Aniello Cerrato, Angela Celetti

Ccdc6 knock-in mice develop thyroid hyperplasia associated to an enhanced CREB1 activity

Ccdc6 基因敲入小鼠发生甲状腺增生,与 CREB1 活性增强有关

Vincenza Leone, Concetta Langella, Francesco Esposito, Claudio Arra, Giuseppe Palma, Domenica Rea, Orlando Paciello, Francesco Merolla, Davide De Biase, Serenella Papparella, Angela Celetti, Alfredo Fusco

Identification of sumoylation sites in CCDC6, the first identified RET partner gene in papillary thyroid carcinoma, uncovers a mode of regulating CCDC6 function on CREB1 transcriptional activity

CCDC6 是第一个在甲状腺乳头状癌中发现的 RET 伴侣基因,在该基因中鉴定出 SUMO 化位点,揭示了一种调节 CCDC6 功能对 CREB1 转录活性的模式

Chiara Luise, Francesco Merolla, Vincenza Leone, Simona Paladino, Daniela Sarnataro, Alfredo Fusco, Angela Celetti